Kedar Purushottam Phadke
Nessuna posizione attualmente
Storia della carriera di Kedar Purushottam Phadke
Precedenti posizioni note di Kedar Purushottam Phadke
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| THERMAX LIMITED | Responsabile della Conformità | 08/08/2017 | 19/08/2021 |
| Contatto Relazioni con gli Investitori | 08/08/2017 | 19/08/2021 | |
| Segretario Aziendale | 08/08/2017 | 19/08/2021 | |
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Segretario Aziendale | 19/11/2010 | - |
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | Consigliere Generale | 01/12/2009 | - |
| Segretario Aziendale | 01/12/2009 | - |
Statistiche
Distribuzione geografica
| India | 4 |
Posizioni
| Corporate Secretary | 3 |
| General Counsel | 1 |
| Compliance Officer | 1 |
Settori
| Producer Manufacturing | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | Producer Manufacturing |
| THERMAX LIMITED | Producer Manufacturing |
| Aziende private | 1 |
|---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
